Retrospective Study
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 88-94
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.88
Table 1 Baseline demographics and patient characteristics
ParameterOverall, n = 177Genotype 1
Genotype 2 SOF/RBV n = 42
IFN/TVR/RBV n = 5IFN/SMV/RBV n = 11DCV/ASV n = 43LDV/SOF n = 66OBV/PTV/r n = 10
Age, median167.8 (11.0)62.9 (8.7)60.2 (8.9)72.7 (8.3)66.0 (11.2)70.9 (6.5)67.5 (12.6)
> 65, n (%)118 (66.7)3 (60)4 (36.4)37 (88.1)39 (59.0)7 (70)29 (67.4)
Sex, n (%)
Male79 (44.6)3 (60)7 (63.6)14 (32.6)31 (47.0)4 (40)20 (47.6)
Female98 (55.4)2 (40)4 (36.4)29 (67.4)35 (53.0)6 (60)22 (52.4)
HCV RNA, median Log10 LGE16.1 (0.8)6.5 (0.56)6.2 (1.1)6.30 (0.5)6.16 (0.6)5.4 (0.9)5.8 (0.9)
> 100000 IU/mL, n (%)109 (61.6)4 (80)9 (81.8)32 (76.2)43 (0.7)2 (20)19 (45.2)
Cirrhosis present, n (%)
Yes74 (41.8)0 (0)0 (0)34 (79.0)29 (44.0)3 (30)8 (18.6)
No103 (58.2)5 (100)11 (100)9 (20.1)37 (56.0)7 (70)34 (81.4)
HCV treatment history, n (%)
Naïve132 (74.6)1 (20)2 (18.2)25 (58.1)63 (95.5)9 (90)32 (76.2)
Prior IFN-based treatment45 (25.4)4 (80)9 (81.8)18 (41.8)3 (4.5)1 (1)10 (23.8)
History of HCC, n (%)
Yes26 (14.7)1 (20)0 (0)19 (44.1)3 (4.5)0 (0)3 (9)
No151 (85.3)4 (80)11 (100)24 (55.8)63 (95.5)10 (100)39 (90.7)
Laboratory values
Baseline platelet count, mean (× 104/μL)115.1 (6.5)15.4 (3.4)15.1 (6.2)11.5 (5.8)15.5 (6.5)18.0 (5.96)17.6 (6.0)
Baseline ALT level, mean (IU/L)151.2 (37.3)41.8 (9.7)50.1 (50.5)53.1 (27.8)60.3 (45.2)39.9 (26.8)38.9 (28.6)
Baseline AFP level, mean (ng/mL)112.1 (17.6)5.6 (1.6)7.18 (9.1)23.4 (27.2)8.99 (11.6)9.9 (11.6)6.8 (6.9)